id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OPP-2017-0440-0018,EPA,EPA-HQ-OPP-2017-0440,"Agency Information Collection Activities; Proposals, Submissions, and Approvals: Plant Incorporated Protectants; Confidential Business Information Substantiation and Adverse Effects Reporting, Renewal",Notice,,2020-12-17T05:00:00Z,2020,12,2020-12-17T05:00:00Z,2021-01-20T04:59:59Z,2020-12-17T16:54:44Z,2020-27801,0,0,09000064849a43b7
EPA-HQ-OPP-2017-0440-0016,EPA,EPA-HQ-OPP-2017-0440,Plant-Incorporated Protectants; CBI Substantiation and Adverse Effects Reporting OMB No.: 2070-0142 EPA ICR No.: 1693.10,Supporting & Related Material,ICR Supporting Statement,2020-09-17T04:00:00Z,2020,9,,,2020-10-04T01:29:13Z,,0,0,09000064846601f3
EPA-HQ-OPP-2017-0440-0015,EPA,EPA-HQ-OPP-2017-0440,"Agency Information Collection Activities; Proposals, Submissions, and Approvals",Notice,,2020-08-17T04:00:00Z,2020,8,2020-08-17T04:00:00Z,2020-10-17T03:59:59Z,2020-10-04T01:28:51Z,2020-17901,0,0,0900006484809f5e